CNY 13.8
(-0.43%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 50.63 Million | 119.91 Million | 71.1 Million | 64.47 Million | 93.27 Million | 36.98 Million |
Net Income | 64.31 Million | 37.74 Million | 95.4 Million | 91.2 Million | 86.24 Million | 81.33 Million |
Depreciation & Amortization | 28.9 Million | 24.23 Million | 27.86 Million | 23.17 Million | 24.33 Million | 25.22 Million |
Deferred income taxes | 4.07 Million | 3.83 Million | 1.7 Million | 712.56 Thousand | -822.77 Thousand | -1.25 Million |
Stock-based compensation | - | 124.44 Thousand | 1.02 Million | - | 1.02 Million | 542.83 Thousand |
Change in working capital | -69.77 Million | 41.42 Million | -63.75 Million | -69.19 Million | -32.16 Million | -89.47 Million |
Other non-cash items | 296.31 Thousand | 16.51 Million | 11.58 Million | 19.28 Million | 14.86 Million | 19.89 Million |
Investing Cash Flow | -108.25 Million | -67.32 Million | -79.49 Million | -59.26 Million | -9.01 Million | -14.46 Million |
Investments in PPE | -140.44 Million | -68.25 Million | -81.99 Million | -60.11 Million | -9.82 Million | -12.07 Million |
Acquisitions | 2.17 Million | 2.05 Million | 4.6 Million | 1.88 Million | 803.47 Thousand | -2.91 Million |
Investment purchases | - | - | -10 Thousand | - | - | 335.6 Thousand |
Sales/Maturities of investments | - | - | 10 Thousand | - | - | 201.67 Thousand |
Other Investing Activities | 30.55 Million | -1.12 Million | -2.1 Million | -1.02 Million | -9.82 Million | -9974.09 |
Financing Cash Flow | -61.63 Million | -57.89 Million | -12.3 Million | 251.92 Million | -42.75 Million | -7.3 Million |
Debt repayment | -9.24 Million | -4.62 Million | -251.25 Thousand | -79.4 Million | -123.2 Million | -161.29 Million |
Dividends payments | -52.1 Million | -50.05 Million | -40.04 Million | -20.2 Million | -9.82 Million | -18.18 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -291.79 Thousand | -2.23 Million | 28.25 Million | 352.72 Million | 96.02 Million | 172.17 Million |
Accounts receivables | -76.19 Million | 35.17 Million | -28.36 Million | -69.54 Million | -43.9 Million | -34.19 Million |
Accounts payables | 35.52 Million | -20.82 Million | 21.43 Million | -11.38 Million | 14.8 Million | 8.12 Million |
Inventory | -33.17 Million | 23.23 Million | -58.53 Million | 11.02 Million | -2.23 Million | -62.14 Million |
Other working capital | 39.6 Million | 3.83 Million | 1.7 Million | 712.56 Thousand | -822.77 Thousand | -27.32 Million |
Cash at beginning of period | 360.46 Million | 365.19 Million | 385.95 Million | 128.82 Million | 87.31 Million | 72.01 Million |
Cash at end of period | 242.07 Million | 360.46 Million | 365.19 Million | 385.95 Million | 128.82 Million | 87.31 Million |
Capital Expenditure | -140.44 Million | -68.25 Million | -81.99 Million | -60.11 Million | -9.82 Million | -12.07 Million |
Effect of forex changes on cash | 860.81 Thousand | 584.51 Thousand | -67.55 Thousand | -21.53 Thousand | 8051.93 | 89.19 Thousand |
Net cash flow / Change in cash | -118.39 Million | -4.72 Million | -20.75 Million | 257.12 Million | 41.51 Million | 15.3 Million |
Free Cash Flow | -89.81 Million | 51.65 Million | -10.88 Million | 4.36 Million | 83.45 Million | 24.9 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 11.51 Million | 8.7 Million | 10.89 Million | 64.31 Million | 17.26 Million | 18.79 Million |
Depreciation & Amortization | - | 7.43 Million | 7.43 Million | 28.9 Million | 7.31 Million | -14.18 Million |
Deferred income taxes | - | - | - | 4.07 Million | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | -69.77 Million | -109.37 Million | 31.2 Million |
Other non-cash items | 59.92 Million | -1.41 Million | -4.71 Million | 296.31 Thousand | -4.41 Million | -27.65 Million |
Investing Cash Flow | -5.57 Million | -3.86 Million | -13.86 Million | -108.25 Million | -4.32 Million | -23.98 Million |
Investments in PPE | -5.79 Million | -4.24 Million | -14.19 Million | -140.44 Million | -1.78 Million | -24.52 Million |
Acquisitions | 1.98 Million | 380.99 Thousand | 327 Thousand | 2.17 Million | 287.2 Thousand | 1.13 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 220 Thousand | 380.99 Thousand | 327 Thousand | 30.55 Million | -2.87 Million | -588 Thousand |
Financing Cash Flow | -3.72 Million | -59.14 Million | -4.71 Million | -61.63 Million | -1.24 Million | -4.07 Million |
Debt repayment | -4.62 Million | - | -4.62 Million | -9.24 Million | - | -4.62 Million |
Dividends payments | -321.48 Thousand | -54.48 Million | -97.68 Thousand | -52.1 Million | -2.02 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 1.21 Million | -59.14 Million | -97.68 Thousand | -291.79 Thousand | -879.84 Thousand | 550.04 Thousand |
Accounts receivables | - | - | - | -76.19 Million | -76.19 Million | 18.85 Million |
Accounts payables | - | - | - | 35.52 Million | - | - |
Inventory | - | - | - | -33.17 Million | -33.17 Million | 12.34 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 166.67 Million | 229.71 Million | 238.44 Million | 360.46 Million | 242.03 Million | 261.81 Million |
Cash at end of period | 228.78 Million | 166.67 Million | 226.08 Million | 242.07 Million | 242.07 Million | 242.03 Million |
Capital Expenditure | -5.79 Million | -4.24 Million | -14.19 Million | -140.44 Million | -1.78 Million | -24.52 Million |
Effect of forex changes on cash | -32.36 Thousand | 122.44 Thousand | 47.89 Thousand | 860.81 Thousand | 60.83 Thousand | 121.23 Thousand |
Net cash flow / Change in cash | 62.11 Million | -63.03 Million | -12.36 Million | -118.39 Million | 31.73 Thousand | -19.77 Million |
Free Cash Flow | 65.64 Million | -4.38 Million | -8.01 Million | -89.81 Million | 3.75 Million | -16.37 Million |
0KXA
OPCE
CTRN
300539
6069
MRVI